1997
DOI: 10.1006/exnr.1997.6694
|View full text |Cite
|
Sign up to set email alerts
|

Activated Macrophage/Microglial Cells Can Promote the Regeneration of Sensory Axons into the Injured Spinal Cord

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
124
0
6

Year Published

1998
1998
2014
2014

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 245 publications
(136 citation statements)
references
References 54 publications
6
124
0
6
Order By: Relevance
“…Astrogliosis is a hallmark of wound healing, since astrocytes are the main source of neuroprotective/neurotrophic compounds in the CNS (Martin, 1992;Ridet et al, 1997;Yoshida and Toya, 1997), while neovascularization is fundamental to re-establish blood supply and reduce secondary anoxic/hypoxic damage. Finally, there is increasing evidence about a neurotrophic/neuroprotective action of microglia/macrophages (Elkabes et al, 1996;Zietlow et al, 1999;Rabchevsky and Streit, 1997;Chamak et al, 1994;Prewitt et al, 1997;Suzuki et al, 2001;Polazzi et al, 2001). On this basis, therapeutic strategies directed to reducing secondary neuronal damage should be preferably designed not to reduce the microglia/macrophage reaction per se but rather to specifically inhibit the detrimental activities of reactive microglia/macrophages.…”
Section: Proliferative Origin and Fate Of Microgliamentioning
confidence: 99%
“…Astrogliosis is a hallmark of wound healing, since astrocytes are the main source of neuroprotective/neurotrophic compounds in the CNS (Martin, 1992;Ridet et al, 1997;Yoshida and Toya, 1997), while neovascularization is fundamental to re-establish blood supply and reduce secondary anoxic/hypoxic damage. Finally, there is increasing evidence about a neurotrophic/neuroprotective action of microglia/macrophages (Elkabes et al, 1996;Zietlow et al, 1999;Rabchevsky and Streit, 1997;Chamak et al, 1994;Prewitt et al, 1997;Suzuki et al, 2001;Polazzi et al, 2001). On this basis, therapeutic strategies directed to reducing secondary neuronal damage should be preferably designed not to reduce the microglia/macrophage reaction per se but rather to specifically inhibit the detrimental activities of reactive microglia/macrophages.…”
Section: Proliferative Origin and Fate Of Microgliamentioning
confidence: 99%
“…Some of the more frequently used cellular interventions have employed fibroblasts (40, 49,59,95,104), been demonstrated to facilitate long-tract regeneration and behavioral recovery in a number of SCI paradigms embryonic stem cells (60,63,100), bone marrow stromal cells (13, 45,61,70), fetal tissue (3), peripheral nerve (9, 29,56,78,79,89). Recent advances in tissue culturing procedures have shown the potential of OEG to be hargrafts (18,19,82), macrophages (34, 77,94), Schwann cells (10,11,72,73,97), and olfactory ensheathing glia vested from either the olfactory bulb (89) or nasal mucosa for autologous transplantation into a spinal cord-(9, 32,78,79,89), often in combination with molecular or pharmacological strategies aimed at increasing neuroinjured individual.…”
Section: Introductionmentioning
confidence: 99%
“…They can become harmful when they synthesise and secrete molecules that increase synaptic overactivity and thus increase the damage already present. They may also alter excitotoxicity, abort apoptosis and encourage the growth of neurite in the injured CNS (Barger et al, 1995;Berezovskaya et al, 1995;Imamura et al, 1990;Lazarov-Spiegler et al, 1996;Prewitt et al, 1997;Rabchevsky and Streit, 1997;Toku et al, 1998). Activated microglias are present in other areas of the CNS and therefore initiate and promote inflammation in different brain regions including the putamen, substantia nigra and cingulated cortex where they are responsible for the generation of lewy bodies (Li et al, 2010;McKeith and Mosimann, 2004;Varani et al, 2010).…”
Section: Parkinson's Diseasementioning
confidence: 99%